Dotmatics

📣 Dotmatics will be attending #AntibodyEng 2025! Visit us at booth 213 to meet with our subject matter experts and learn about Geneious, Luma, and BioGlyph Luma! Also, make sure to attend Christian O.'s talk "Empowering Next-Gen Protein Design: A Multimodal Intelligence Platform for Advanced Immunotherapy" on December 15th at 1:15pm. We look forward to seeing you there! https://lnkd.in/eqU3R8Xq

🔬 Multispecific antibodies are getting more complex, and teams need a shared language that meets the complexity. Our latest blog introduces a universal building block approach and shows how BioGlyph Luma makes that language visual, structured, and easy to work with across teams. Read now! https://lnkd.in/euFBGNP3

MSN recently highlighted how responsible #AI can drive sustainability, from smarter supply chains to more efficient scientific discovery. Dotmatics has been featured as a real world example of AI accelerating research while reducing environmental impact! 🌎 🔗 Visit our page to read the full article: https://lnkd.in/gwhugYbK

Join us Thursday, November 20th at Upland NYC for Discover Dotmatics, an evening to connect with the scientific community and explore how we’re advancing R&D together. Hear from Jessica Biagi and Michael Fritz as they discuss how Dotmatics supports scientists and organizations of all sizes; from individual researchers using specialized apps to global teams connecting data across the Luma platform and Siemens ecosystem. 📍 Upland NYC, 5-8:30PM Register now: https://lnkd.in/gdpyJQTu

If your scientists are part-time file wranglers, the architecture is the issue, not the people. This playbook shows a cleaner path from instrument output to accountable decisions. https://lnkd.in/gQYB6Jr8 #LifeSciences #ScientificData #LabInformatics #Dotmatics

What if the 🌿 greener path is fewer experiments, but smarter ones? In our latest article, Evan Quarnstrom and Alister Campbell break down how AI plus high-quality scientific data reduces duplication and material waste. https://lnkd.in/gwhugYbK #AI #Sustainability #RDSoftware #Dotmatics

R&D leaders: this month’s Innovation Insights is live. Two big events. Fresh AI-in-R&D coverage. Hands-on resources that you can actually use. Read and subscribe now.

If you missed our webinar with Dotmatics,  it’s now available to watch on demand! Precision is paramount in antibody discovery and engineering. Even small errors in sequence design or data integration can cascade through workflows and affect critical outcomes. Hear from the team at Dotmatics and BioGlyph on how maintaining precision across every stage, from design to data integration, drives more reliable and efficient antibody discovery. See how platforms like #Luma and #BioGlyph address long standing challenges in data fidelity and workflow integration, helping researchers make better, faster decisions in antibody R&D. 𝗪𝗮𝘁𝗰𝗵 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝗻𝗼𝘄 𝗼𝗻 𝗼𝘂𝗿 𝗬𝗼𝘂𝗧𝘂𝗯𝗲 𝗰𝗵𝗮𝗻𝗻𝗲𝗹: https://lnkd.in/erz2kXri

R&D teams aren’t short on data. They’re short on answers. 🖥️ Watch our on demand webinar to learn how Luma Lab Connect turns scattered data into outcome-ready insights that accelerate decisions and preserve context for downstream work. Speakers: Michael Fritz and Kelly Harrington Watch now: https://lnkd.in/eG7c2h9r

Dotmatics is heading to PEGS Europe next week in Lisbon, Portugal! 🇵🇹 👋 Visit us at booth 303 to connect with our teams from Protein Metrics, LLC, Geneious, and Luma to discover how we’re advancing protein characterization, biologics development, and multimodal data intelligence. Don't miss our presentations: - "Empowering Next-Gen Protein Design: A Multimodal Intelligence Platform for Advanced Immunotherapy" - presented by Christian O., Thursday, November 13 at 9:30 AM - "Integrated Machine Learning (ML) and Molecular Dynamics (MD) Model to Predict the Developability Profiles of Full-Length Multispecific Antibodies" — presented by Fernando Garces, Thursday, November 13 at 8:30 AM 💡 We’ll also be showcasing the following posters presented by Vahid Golghalyani, PhD, David Podesta and David Lascoux: Progressive Deconvolution Poster: Progressive deconvolution enables robust detection and quantitation of low-abundance proteoforms in complex biologics by iteratively analyzing overlapping chromatogram segments, revealing greater dynamic range than conventional methods. MAM Inter-laboratory Study Poster: Multi-laboratory comparison of NIST mAb analysis demonstrates how Byosphere's dashboard capabilities enable rapid identification of outliers and assessment of reproducibility across different sample preparation methods and MS systems. Byos MPQ + Prism Poster: Integration of Byos Multi-Protein Quantitation with GraphPad Prism streamlines Top-N protein abundance analysis and enables advanced statistical visualization for applications from cell line development to drug purity verification. And from Geneious: "Antibody & Therapeutics Discovery: Interrogating large NGS Datasets": Showcasing how Geneious Biologics allows users to interrogate large antibody sequence datasets quickly, revealing patterns like clonal expansion and enabling efficient candidate selection. - presented by Monica Watson. We look forward to seeing you there! https://lnkd.in/egV3XPum